April 2021 | Contego Medical

Contego Medical, Inc. announced receipt of CE Mark approval for the Neuroguard IEP®

RALEIGH, N.C., April 16, 2021/PRNewswire/ — Contego Medical, Inc., a leading developer of innovative cardiovascular devices, today announced receipt of CE Mark approval for the Neuroguard IEP® 3-in-1 Carotid Stent and Post-Dilation Balloon System with Integrated Embolic Protection (Neuroguard IEP System).

By Adam Rosenkoetter|2021-04-26T05:26:27-07:00April 26th, 2021|News|Comments Off

© 2023 Contego Medical, Inc. All rights reserved. MKT-1374
Paladin, Neuroguard IEP, Vanguard IEP, Excipio, Integrated Embolic Protection, and FlexRing are trademarks or registered trademarks of Contego Medical.